Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Frontiers | Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Cells | Free Full-Text | Molecular Markers and Targets in Melanoma
Immunostaining and high-content analysis of multiple markers in a... | Download Scientific Diagram
Biology | Free Full-Text | Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity
IJMS | Free Full-Text | Markers of Angiogenesis, Lymphangiogenesis, and Epithelial–Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect
Nanomedicines Targeting Glioma Stem Cells | ACS Applied Materials & Interfaces
JCM | Free Full-Text | Tumor Budding: The Name is EMT. Partial EMT.
Frontiers | Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
Percentage of Cells in G0/G1 Phase - an overview | ScienceDirect Topics
Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading | Cell Death & Disease
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis | PLOS ONE
Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer | Molecular Pharmaceutics
Increased CaMKK2 expression is an adaptive response that maintains the fitness of tumor-infiltrating natural killer cells | bioRxiv
![PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a309508e062cbf2202977800a3574dc9cea4a0c3/4-Figure1-1.png "PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar")
PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis | PLOS ONE
JCM | Free Full-Text | Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives | Journal of Medicinal Chemistry
MAP3K8 exhibits pro-tumorigenic properties in HGSC and is a predictive... | Download Scientific Diagram
Challenges in treatment of a patient suffering from neuroendocrine tumor G1 of the hilar bile duct: a case report | BMC Gastroenterology | Full Text
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma | Nature Communications
Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma | Cell Research
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
Cells | Free Full-Text | PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
Cancers | Free Full-Text | Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
IJMS | Free Full-Text | B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy
